ANNX FY 2023 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$144M

Net Income

-$134M

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$121M

Free Cash Flow

-$121M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$298M

Total Liabilities

$47M

Stockholders' Equity

$251M

Cash & Equivalents

$225M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$144M	-$146M	+1.3%
Net Income	-$134M	-$142M	+5.4%